| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |